Ophthalmology · New York, NY
NPI
1386731479
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
205 E 64th St, Suite 101
New York, NY, 10065
Phone (212) 888-4100
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
17,373 services
Medicare patients, 2024
2,672
Average age 78
Drug cost, 2024
$3.0M
10,106 prescriptions
Company payments, 2025
$702
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory K Harmon was code 92012 (ophthalmological e&m), 4,321 times for 2,037 patients. In total Gregory K Harmon billed 17,373 services in 48 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 4,321 | 2,037 | $65.28 | $282K |
| 92083 Vision, Hearing, and Speech Services | Office | 2,331 | 2,166 | $48.47 | $113K |
| 92020 Ophthalmological E&M | Office | 2,291 | 1,948 | $20.05 | $46K |
| 92201 Ophthalmological E&M | Office | 1,798 | 1,560 | $17.97 | $32K |
| 92250 Angiography | Office | 1,560 | 1,335 | $26.67 | $42K |
| 92133 Computerized Ophthalmic Imaging | Office | 1,397 | 1,292 | $26.49 | $37K |
| 92014 Ophthalmological E&M | Office | 838 | 772 | $88.48 | $74K |
| 68760 Eye | Office | 479 | 294 | $242.81 | $116K |
| 92134 Computerized Ophthalmic Imaging | Office | 465 | 419 | $30.28 | $14K |
| 66984 Cataract Surgery | Facility | 290 | 179 | $384.07 | $111K |
| 92004 Ophthalmological E&M | Office | 242 | 242 | $108.68 | $26K |
| 92136 Ultrasound - Nonspecific | Office | 200 | 200 | $36.96 | $7,393 |
| 76514 Ultrasound - Nonspecific | Office | 169 | 169 | $8.60 | $1,453 |
| 66821 Cataract Surgery | Office | 160 | 118 | $249.86 | $40K |
| 67700 Eye | Office | 140 | 94 | $227.16 | $32K |
By year: 2022 $1.3M for 16,736 services; 2023 $1.4M for 18,015 services; 2024 $1.1M for 17,373 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gregory K Harmon prescribed most often to Medicare patients was Latanoprost, with 1,380 prescriptions and refills. In total Gregory K Harmon wrote 10,106 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,380 | 3,080 | 373 | $17K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 799 | 1,816 | 200 | $16K |
| Restasis Cyclosporine | 731 | 1,434 | 266 | $853K |
| Prednisolone Acetate Generic | 585 | 913 | 375 | $23K |
| Timolol Maleate Generic | 580 | 1,341 | 164 | $5,956 |
| Brimonidine Tartrate Generic | 505 | 1,035 | 139 | $13K |
| Ciprofloxacin Hcl Generic | 394 | 547 | 273 | $7,214 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 315 | 324 | 229 | $3,372 |
| Lumigan Bimatoprost | 297 | 562 | 67 | $162K |
| Xiidra Lifitegrast | 292 | 486 | 83 | $328K |
| Dorzolamide Hcl Generic | 289 | 615 | 77 | $5,807 |
| Pilocarpine Hcl Generic | 263 | 782 | 75 | $16K |
| Combigan Brimonidine Tartrate/Timolol | 257 | 480 | 62 | $115K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 242 | 379 | 47 | $140K |
| Alphagan P Brimonidine Tartrate | 212 | 431 | 54 | $115K |
Brand drugs: 5,391 claims; generic drugs: 4,715 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory K Harmon $702 ($702 in general payments such as food, travel and fees) from 9 companies. The largest payer was Bausch & Lomb Americas Inc. with $124.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 1 | $124 |
| Alcon Vision LLC ALC | 4 | $103 |
| Thea Pharma Inc. | 4 | $95.26 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $84.8 |
| Dompe US, Inc. | 3 | $79.31 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $75.21 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 3 | $55.72 |
| Amgen Inc. AMGN | 2 | $42.73 |
| Abbvie Inc. ABBV | 2 | $41.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.